US2005032148A1PendingUtilityA1
Diagnostic agents for pancreatic exocrine function
Priority: Sep 25, 1998Filed: Aug 25, 2004Published: Feb 10, 2005
Est. expirySep 25, 2018(expired)· nominal 20-yr term from priority
A61K 51/1268A61K 49/10C08B 37/00A61K 51/1206A61K 49/126B82Y 5/00A61K 49/1815C07H 3/06A61K 51/0491A61K 49/189A61K 51/06
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a 13 C-labeled oligosaccharide or polysaccharide or a salt thereof excluding U- 13 C-maltose, 13 C-starch, 1- 13 C-maltotetraose and 1- 13 C-amylose; a derivative of the 13 C-labeled oligosaccharide or polysaccharide or salt thereof; a 13 C-labeled inclusion complex or a salt thereof, which comprises a cyclodextrin or a modified derivative thereof as a host molecule; a 13 C- or 14 C-labeled fluorescein ester compound or a salt thereof; and a diagnostic agents for pancreatic exocrine function comprising these compounds 13 C- or 14 C-labeled.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled
10 . (canceled)
11 . (canceled).
12 . (canceled)
13 . (canceled)
14 . (canceled).
15 . (canceled)
16 . (canceled)
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . (canceled)
21 . (canceled)
22 . A method of diagnosing pancreatic exocrine function comprising administering a 13 C- or 14 C-labeled inclusion complex or a salt thereof having a cyclodextrin or a modified derivative thereof as a host molecule.
23 . (canceled)
24 . (canceled)
25 . (canceled)
26 . (canceled)
27 . (canceled)
28 . (canceled)
29 . (canceled)
30 . (canceled)
31 . (canceled)
32 . (canceled)
33 . (canceled)
34 . (canceled)
35 . (canceled)
36 . (canceled)
37 . (canceled)
38 . (canceled)
39 . (canceled)
40 . (canceled)
41 . (canceled)
42 . (canceled)Join the waitlist — get patent alerts
Track US2005032148A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.